India's Lupin clears patent hurdle with Astellas Pharma, keeps Mirabegron sales in US
You can't rely on indexes to pick international stocks, this 5-star fund manager says. Here are 3 of his top selections.
Japan's Astellas Pharma to buy Iveric Bio in deal worth $5.9 billion